Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 19, 2019 (7 years ago)

MIC (Methionine/Inositol/Choline Chloride)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

MIC (METHIONINE/INOSITOL/CHOLINE CHLORIDE) 25/50/50 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0100-30

Affected NDC 70731-0100-30

Compare with the code on your package — it is the most precise check available.

Drug: Methionine

Recalling firm
RXQ Compounding LLC
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1680-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Methionine recalls

See all
Class II · Moderate risk

LX Bioboost Plus

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0477-2025
Class II · Moderate risk

Micc

Lack of assurance of sterility.

Completed Sterility / contamination Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0052-10 D-0937-2022

Other recalls by RXQ Compounding LLC

All 2019 recalls